Oregon Overdose Data Dashboard User Agreement

Subscribe for dashboard updates!
Receive updates about new data or new features on the dashboard by subscribing.

Have a question or feedback?
Submit any questions or feedback here and we will get back to you as soon as possible.

By selecting "I Agree" below, the user agrees to:

  • Notify us of publications or products using this data.
  • Cite the sources of these data in publications or products.
  • Do not attempt to try to identify individuals in this data.

Oregon Health Authority logo
Oregon Overdose Prevention Dashboard
  • Home
  • SUDORS
  • Hospital & ED Visits
  • Deaths
  • Reports
  • More Information
    • Data Description
    • Definitions
    • Technical Notes

53%

of overdose deaths involved opioids with stimulants in 2023 (SUDORS).

9,704

Overdose-related emergency department visits in 2024 (Hospital & ED Visits).

1,833

people died of an overdose in 2023 (Deaths).

This dashboard contains information related to drug overdose deaths. Oregon’s overdose crisis has affected every community across the state, and the highly sensitive and traumatic nature of these events have caused harm, trauma, and loss that impact the well-being of everyone.

About this dashboard

An overdose, sometimes referred to as an OD, happens when the body is overwhelmed by a toxic amount of a substance or combination of substances. It’s possible to overdose on substances that are prescribed, over the counter, legal, illicit, or non-medicinal. Symptoms of a drug overdose depend on what substance the person used. Common signs of an opioid overdose include loss of consciousness and difficulty breathing. Any overdose is a medical emergency and can lead to death.

Oregon’s Injury and Violence Prevention Program (IVPP) uses data from a variety of sources to understand overdoses and the substances involved. An overdose can be reported in multiple categories if more than one substance was involved. For example, if an overdose death involved both opioids and stimulants that death would be included in both the opioid and stimulant categories.

Check out our “Reports” tab for additional report links and more details on the drug overdose crisis in Oregon.

This dashboard contains data for the following categories:

  • All overdoses (includes all overdose categories)
  • Any opioid (includes all opioid categories)
  • Benzodiazepines
  • Fentanyl (implemented October 2020)
  • Heroin
  • Methadone
  • Natural/semi-synthetic opioids
  • Stimulants
  • Synthetic opioids
  • Unintentional and undetermined intent overdoses
  • Unspecified opioids/narcotics

Versions and Updates

A summary of the dashboard updates can be found below:


08/21/2025 (Version 2.5)

Data update: The dashboard data have been refreshed. SUDORS monthly data are now current through January 2025. Hospital and emergency department visit data for the first quarter of 2025 have been added along with preliminary death data for 2024.


06/18/2025 (Version 2.4)

Data and Content update: The Reports page has been updated with new content from the 2024 Opioids and the Ongoing Drug Overdose Crisis in Oregon legislative report. This page also includes updated links to new resources, including new dashboards. Additionally, the SUDORS monthly data were updated and are now current through November 2024.


05/13/2025 (Version 2.3)

Data update: All preliminary data has been updated to reflect the most up-to-date values available. The SUDORS monthly data are now current through October 2024, with new quarterly values included. Hospital and emergency department visit data for Q4 2024 has been added. Annual 2024 data for hospital and emergency department visits are now available for statewide, county-level, and demographic plots. Additionally, Q3 2024 preliminary death data has been added.


02/18/2025 (Version 2.2)

Data and dashboard update: Dashboard navigation has been updated to enhance usability. A Next and Previous button was added to simplify navigating between pages. The value boxes on the Home page are now clickable and will redirect users to the relevant data page for the highlighted data set. The layout of the data pages was reorganized, with similar data sets grouped together for easier comparison. New data for Q3 2024 hospital and emergency department visits has been added. Additionally, Q1 and Q2 2024 preliminary death data has been updated to reflect the most current values available.


01/07/2025 (Version 2.1)

Data update: The Oregon State Unintentional Drug Overdose Reporting System (SUDORS) data have been updated. This dashboard now includes SUDORS data for April 2024. Additionally, monthly and xylazine-specific counts for 2024 have been updated to reflect the most recent data. Going forward, the monthly SUDORS plot will be updated on a monthly basis. To maintain a streamlined version log, routine monthly data updates will not be included. However, major updates or enhancements will continue to be documented in the version log.


12/05/2024 (Version 2.0)

DASHBOARD UPDATE: The overdose dashboard has been redesigned thanks to feedback the IVPP team received over the last year. Interacting with the dashboard should be faster and all the data shown should be easily downloadable for users. Additionally, we have integrated a new data tab! Oregon State Unintentional Drug Overdose Reporting System (SUDORS) data are now available with a special highlight on xylazine and alcohol-related data. All rate data has been updated to use the U.S. Census Bureau’s Population Estimates. Data for 2023 has been finalized and preliminary data for Q1 and Q2 2024 has been updated. If you are looking for a previous version of the dashboard, please click here.


04/30/2024 (Version 1.4)

Bug Fix and Content Update: Removed By Age Group plot in Demographics tab due to an issue in the rates calculation leading to incorrect data being displayed. The By Age Group and Sex plot is correct and provides greater detail than the removed plot. The By Age Group and Sex plot will remain on the dashboard. If you want analysis by age group alone, please contact us and we can provide this information.


03/13/2024 (Version 1.3.1)

Data Update: Thank you users and community for reporting feedback. The overdose death data have been updated to include 2022. The ‘Unintentional Overdose’ category now includes both unintentional and undetermined intent overdoses to better align with the Oregon State Unintentional Drug Overdose Reporting System (SUDORS) reporting. The race category reported for overdose deaths that report more than one race will be based on the least common race. This is sometimes called rarest race methodology. Least common race is based on Oregon population estimates for the most current year.


07/26/2023 (Version 1.3)

Bug Fix and Content Update: Thank you for reaching out and reporting feedback! The county-level counts/rates issue has been resolved. Definitions and drug categories have been updated to provide further clarity and description. Added links to other IVPP dashboards.


06/09/2023 (Version 1.2)

Content update: Context around the hospital and emergency department data has been added, including an addition to the Technical Notes about fentanyl-related death data.


05/26/2023 (Version 1.1)

DATA UPDATE! Preliminary mortality and finalized hospital and emergency department discharge trends are now available for 2022 in the State Trends tab. Caution: Mortality data for 2022 are preliminary and values may change once finalized.


05/05/2023 (Version 1.0)

Oregon Overdose Prevention Dashboard is released. Data presented in this dashboard include finalized values from 2021. Full-year 2022 data are not yet available.

Data Sources

This dashboard contains 3 data sets:

SUDORS

Oregon State Unintentional Drug Overdose Reporting System (SUDORS) collected from medical examiner records and death certificate data.

Updated monthly.

Hospital/Emergency Department

Administrative discharge data from the Hospital Association of Oregon.

Updated quarterly.

Death/Mortality

Death certificate data available from the Oregon Center for Health Statistics.

Updated annually.

This information can be used along with community input to develop prevention efforts and comes from the following sources:

  • Administrative Discharge Data for hospital and emergency department visits from the Hospital Association of Oregon
  • Death and morbidity data from the Oregon Center for Health Statistics. Note: Definitions and terms may vary.
  • Population data from the U.S. Census Bureau's Population Estimates

Contact us

Subscribe for updates

Do you want to receive an e-mail notification when the data are updated? Subscribe below.

Have questions?

You can send your questions to IVPP.General@oha.oregon.gov, or submit your question/feedback using the button below.

State Unintentional/Undetermined Drug Overdose Reporting System (SUDORS)


Contents

  • About SUDORS
  • Monthly Trends
  • Quarterly & Annual Trends
  • Xylazine & Alcohol Highlight
  • Demographic Trends
  • County Trends
  • Additional Notes

Submit your questions and feedback below.

About SUDORS

The Oregon State Unintentional Drug Overdose Reporting System (SUDORS) is part of the Overdose Data to Action in States (OD2A-S) Project funded by the Center of Disease Control and Prevention (CDC). SUDORS is an addition to the National Violent Death Reporting System (NVDRS) and gathers information on unintentional and undetermined drug overdose deaths that happened in Oregon. A death due to toxication of alcohol alone is not included in SUDORS. For more information, see the Additional Notes.

SUDORS has five data components: decedents’ demographics, injury and death, circumstances surrounding incident, toxicology results, and overdoses. Data from death certificates and medical examiner reports are manually abstracted and saved into the SUDORS national system.

Oregon SUDORS started July 2019.

This dashboard contains information related to drug overdose deaths. Oregon’s overdose crisis has affected every community across the state, and the highly sensitive and traumatic nature of these events have caused harm, trauma, and loss that impact the well-being of everyone.

Monthly Overdose Trends in Oregon (Last Updated: Oct 08, 2025)

Select your criteria and see the updated trends in the graphs and tables below.


  • Count
  • Cumulative Count
Loading...

Additional Notes:

  • Categories are not mutually exclusive. Deaths involving multiple drugs are included in the counts for each drug.
  • Opioid includes deaths that had at least one opioid listed as a cause of death, including illegally-made fentanyls, heroin, prescription opioids, and any other opioids involved in overdose deaths.
  • Stimulant includes deaths that had at least one stimulant listed as a cause of death, including cocaine, methamphetamine, and any other stimulants involved in overdose deaths.
  • Preliminary SUDORS data (represented by dashed line) represent information that has not undergone the same quality control measures as the finalized data. This data is shown to provide more recent trends of the overdose crisis in Oregon. Preliminary data may change once finalized and are not available for download.

Additional Notes:

  • Categories are not mutually exclusive. Deaths involving multiple drugs are included in the counts for each drug.
  • Opioid includes deaths that had at least one opioid listed as a cause of death, including illegally-made fentanyls, heroin, prescription opioids, and any other opioids involved in overdose deaths.
  • Stimulant includes deaths that had at least one stimulant listed as a cause of death, including cocaine, methamphetamine, and any other stimulants involved in overdose deaths.
  • Preliminary SUDORS data (represented by dashed line) represent information that has not undergone the same quality control measures as the finalized data. This data is shown to provide more recent trends of the overdose crisis in Oregon. Preliminary data may change once finalized and are not available for download.




Download Data

Quarterly and Annual Overdose Trends in Oregon

Select your criteria and see the updated trends in the graphs and tables below.






Download Data




Download Data

  • Count
  • Percent


Download Data

Additional Notes

  • The largest percentage of deaths involved opioids with stimulants.
  • Someone can have more than one drug type identified as a cause of death, also called polysubstance overdoses. Polysubstance overdoses have become more common in recent years, especially the combination of an opioid and a stimulant.

Drug of Interest in Oregon

Xylazine


Number of detections and deaths involving xylazine among drug overdose deaths in Oregon

All deaths involving Xylazine were co-involved with fentanyl.

(Last Updated: Oct 08, 2025 )



Alcohol


Alcohol use/use suspected among unintentional/undetermined drug overdose deaths, Oregon, 2020-2023

Demographic Trends in Oregon

Select your criteria and see the updated trends in the graphs and tables below.




Download Data


Download Data

Select your criteria and see the updated trends in the graphs and tables below.




Download Data

County Trends

Select your criteria and see the updated trends in the graphs and tables below.





Download Data

Note: Be cautious when comparing county rates with fewer than 20 deaths because those rates may not be statistically stable.


Select your criteria and see the updated trends in the graphs and tables below.



Select county of interest (up to 4):




Download Data

Data come from death certificate information, medical examiner or coroner reports, and forensic toxicology results entered into the State Unintentional Drug Overdose Reporting System (SUDORS). Jurisdictions report occurrent drug overdose deaths (i.e., all overdose deaths that occurred within the jurisdiction regardless of decedent residence).

A drug overdose death in SUDORS is any death caused by acute drug toxicity, where “drug” is defined as any chemical compound that is chiefly used by or administered to humans or animals as an aid in the diagnosis, treatment, or prevention of disease or injury, for the relief of pain or suffering, to control or improve any physiologic or pathologic condition, or for the feeling it causes.

This definition specifically includes:

  • Illicit drugs such as heroin, cocaine, and illicit hallucinogens

  • Prescription drugs

  • Over-the-counter drugs

  • Biological substances such as vaccinations

  • Veterinary drugs

  • Dietary supplements; and

  • Non-medicinal substances used primarily for the feeling they cause.

This definition specifically excludes:

  • Alcohol

  • Tobacco; and

  • Chemicals that are deliberately inhaled for the feeling they cause but are chiefly used for other purposes (i.e. organic solvents and halogen derivatives of aliphatic and aromatic hydrocarbons).

When a person dies in Oregon, more than one race can be reported on their death certificate. This information is not able to be provided by the decedent, so their race and ethnicity information may not accurately reflect how they self-identified. On this dashboard, when more than one race is reported for a person, their least common reported race is used for counts and rates. This is sometimes called rarest race methodology .This approach has its limitations, but it amplifies the representation of Oregon's smaller communities.

The number of deaths, and corresponding rates, in SUDORS might not match the number and rate in CDC’s Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) or the death data on this dashboard.

For national SUDORS data, visit the CDC SUDORS Dashboard: Fatal Drug Overdose Data Dashboard.

Hospital and Emergency Department (ED) Visit Data


Contents

  • About Data
  • Quarterly & Annual Trends
  • Demographic Trends
  • County Trends
  • Additional Notes

Submit your questions and feedback below.

About the data

Hospitalization and Emergency Department discharge data includes information on all inpatient and ED visits with any associated charge. Information includes the diagnoses, procedures performed, total charges and patient demographics. If a person is first seen in the emergency department and later admitted during the same visit, the record will be included in the hospitalization discharge data and excluded from the ED discharge data. Information for outpatient visits are not included. Not all people who experience an overdose encounter the hospital/health care system and the counts below are an underrepresentation of the number of nonfatal overdoses.

Hospitalization and Emergency Department (ED) discharge data is collected and provided by the Hospital Association of Oregon and is provided to OHA IVPP team on a quarterly basis. Inpatient hospitalization data collection began in 2000 and ED discharge data began in 2018.

This dashboard contains information related to drug overdose deaths. Oregon’s overdose crisis has affected every community across the state, and the highly sensitive and traumatic nature of these events have caused harm, trauma, and loss that impact the well-being of everyone.

Quarterly and Annual Trends in Oregon

Select your criteria and see the updated trends in the graphs and tables below.

Select drug type:


  • Quarterly
  • Annual
Loading...



Download Data



Download Data

Demographic Trends in Oregon

Select your criteria and see the updated trends in the graphs and tables below.




Download Data


Download Data





Download Data

County Trends

Select your criteria and see the updated trends in the graphs and tables below.



Select county of interest (up to 4):





Download Data

Select the year of interest:




Download Data

Additional Notes

  • Deaths make up a small percentage of overall emergency department (ED) visits and hospitalizations. The majority of overdose deaths occur outside of a medical setting.

  • Fentanyl was added to the hospital and emergency department data in October 2020. Fentanyl overdose counts and rates will be reported when available. Additional information about fentanyl data can be found in the Technical Notes.

  • Methamphetamine-specific information is not available in this data. If you are interested in information on methamphetamine-related overdose deaths, select the “Stimulants” category.

  • All counts and rates represent Oregon residents only.

  • The rates provided on this dashboard are crude rates. A crude rate is defined as the total number of events (overdoses) divided by the total population of the selected geography, demographic, or community (per 100,000 people).

  • To protect the privacy of individuals, their families and community, data are not shown whenever the counts fall below certain thresholds. Please see the Technical Notes for more details.

  • When interpreting demographic data, it is important to remember that many of these populations have been disproportionately affected by systemic racism, colonialism, social-economic-political injustices, and bias. These inequities can worsen health outcomes and increase the risk of experiencing a fatal or non-fatal overdose.

  • Because of limitations in the data sets with respect to sex and gender, only Male and Female categories are shown. Please see Technical Notes for more details.

  • Refused, Other, and Unknown categories signify those not represented by named categories or those who did not want to disclose.

  • If you are interested in more information on how the overdose counts and rates are presented, please contact us and we will work with you to provide the requested information.

Death Data


Contents

  • About Data
  • Quarterly & Annual Trends
  • Demographic Trends
  • County Trends
  • Additional Notes

Submit your questions and feedback below.

About the data

Death certificates provide information about the individual’s cause, or reason, for death along with the person’s demographics. Not all deaths are certified by a medical examiner in Oregon, therefore not all deaths will have a toxicology test performed. This may lead to an underrepresentation of overdose-related deaths.

Death certificate information is provided by the OHA Center for Health Statistics. It takes about a year for the OHA IVPP team to receive the final death certificate data. For example, the final numbers for a calendar year (e.g., 2023) will be available by the winter of the next calendar year (e.g., 2024). Provisional data is shown in this dashboard as it may change as more information is collected.

This dashboard contains information related to drug overdose deaths. Oregon’s overdose crisis has affected every community across the state, and the highly sensitive and traumatic nature of these events have caused harm, trauma, and loss that impact the well-being of everyone.

Quarterly and Annual Trends in Oregon

Select your criteria and see the updated trends in the graphs and tables below.

Select drug type:

(Fentanyl-related deaths are included in opioid deaths.)

  • Quarterly
  • Annual
Loading...



Download Data



Download Data

Demographic Trends

Select your criteria and see the updated trends in the graphs and tables below.




Download Data


Download Data



Download Data

County Trends

Select your criteria and see the updated trends in the graphs and tables below.


Select county of interest (up to 4):




Download Data

Select the year of interest:




Download Data
  • All fatal overdose counts and rates represent only Oregon residents who died in Oregon.

  • Fentanyl-specific information is not available in this data. If you are interested in information on fentanyl-related overdose deaths, select the “Synthetic opioid” category.

  • Methamphetamine-specific information is not available in this data. If you are interested in information on methamphetamine-related overdose deaths, select the “Stimulants” category.

  • The rates provided on this dashboard are crude rates. A crude rate is defined as the total number of events (overdoses) divided by the total population of the selected geography, demographic, or community (per 100,000 people).

  • To protect the privacy of individuals, their families and communities, data are not shown whenever the counts fall below certain thresholds. Please see the Technical Notes for more details.

  • When interpreting demographic data, it is important to remember that many of these populations have been disproportionately affected by systemic racism, colonialism, social-economic-political injustices, and bias. These inequities can worsen health outcomes and increase the risk of experiencing a fatal or non-fatal overdose.

  • When a person dies in Oregon, more than one race can be reported on their death certificate. This information is not able to be provided by the decedent, so their race and ethnicity information may not accurately reflect how they self-identified. On this dashboard, when more than one race is reported for a person, their least common reported race is used for counts and rates. This is sometimes called rarest race methodology. This approach has its limitations, but it amplifies the representation of Oregon’s smaller communities.

  • Because of limitations in the data sets with respect to sex and gender, only Male and Female categories are shown. Please see Technical Notes for more details.

  • Other and Unknown categories signify those not represented by named categories or those who did not want to disclose.

  • If you are interested in more information on how the overdose counts and rates are presented, please contact us and we will work with you to provide the requested information.


About Overdoses in Oregon

The Oregon Health Authority (OHA) presents this information with the acknowledgment that it represents the deaths of people whose loss has an enormous impact on their families and communities.

Drug overdoses continue to be a public health crisis in Oregon. Fatal and nonfatal overdoses continue to increase across the state. In 2023, 1,833 people died of a drug overdose, an increase of 33% compared to 1,383 deaths in 2022. Oregon health care systems continue to be heavily affected by overdose-related encounters, including emergency medical services (EMS) encounters, emergency department (ED) visits, urgent care visits, and inpatient hospitalizations. In 2023, there were 4,396 inpatient hospitalizations associated with a drug overdose and 11,676 overdose-related ED visits.

A limitation of Oregon’s overdose data systems is that a person must interact with the health care system for an overdose to be counted. Many overdoses may be reversed by community members, friends, and family members using opioid overdose reversal medications like naloxone. If a person does not receive health care services following an overdose, their experience is missed by current overdose monitoring systems. This may lead to an under reporting of nonfatal Oregon overdoses.

Nationally in 2023, the number of overdose deaths decreased for the first time since 2018. However, the number of people dying from overdose in Oregon reached a new high in 2023. This can be partially explained by the timing of the of illicitly manufactured fentanyl, a very potent synthetic opioid, into illicit markets across the country. Illicitly manufactured fentanyl (IMF) became significantly more prevalent in the Oregon illicit drug supply starting in 2020, more than 5 years after the drug’s appearance in eastern states. Eastern and Midwestern states have had more time for fentanyl’s impact on the local population of people who use drugs to generally stabilize. This means that Oregon has only recently experienced the dramatic overdose increases that occurred in Eastern and Midwestern states several years ago. This trend is consistent in other Western states, including Washington and California.

Preliminary data signify a decrease in fatal and nonfatal overdoses in Oregon from 2023 to 2024. It is too early to determine the reasons for this shift, but some possibilities include increased naloxone availability in the community, a strengthened substance use disorder treatment system, and a shift in the local illicit drug market. It is also too early to determine if this decreasing trend will continue.

While a decrease in overdose morbidity and mortality is notable, Oregon’s substance use and overdose rates represent an ongoing and complex public health crisis created by multiple social, economic, and systemic factors. There is no single policy, initiative, or intervention that one agency, sector, or system of the state could implement to fix what has been decades in the making. Implementing a population health approach that includes both upstream and downstream initiatives can decrease substance use initiation, regular use, and harmful use and promote improved quality of life and well-being among Oregonians.

Overdoses are just the tip of the iceberg of the larger issue of substance use disorder (SUD). Not everyone who experiences an SUD will have an overdose, but their life may still be heavily impacted by their substance use. There is a general lack of available resources and treatment program capacity for people with SUD. This trend is seen across the country and not just in Oregon.

Another challenge is how quickly the illicit drug market is changing. The variability in local drug supplies can be harmful to people who use drugs, who may underestimate the potency of the substances they are using or who may be unaware that their substances are adulterated with other drugs. Oregon’s illicit drug market now includes the veterinary tranquilizer xylazine and other emerging substances of concern. Emerging substances present unique challenges because their effect may be unpredictable or unwanted. Clinicians may not know how to properly treat individuals experiencing negative health effects from emerging substances. Emerging substances may not be included in drug tests, drug checking kits, or toxicology tests. This can cause delays in understanding the prevalence of the emerging substance and the most effective medical treatment for its effects.

Additional Information

Here are some links focused on Oregon overdoses:

  • OHA’s Opioid Overdose and Misuse webpage

  • OHA’s Opioid Overdose Update Dashboard (updated monthly)

  • NEW OHA’s EMS Response to Illicit Opioid Overdose Calls Map (updated daily)

  • OHA Oregon Prescribing Dashboard

  • NEW 2024 Opioids and the Ongoing Drug Overdose Crisis in Oregon (report to the legislature)

    • Previous Reports:
      • 2023 Opioids and the Ongoing Drug Overdose Crisis in Oregon

      • 2022 Opioids and the Ongoing Drug Overdose Crisis in Oregon

  • The Substance Use and Overdose Continuum Digest

Data Description


Injury and Violence Prevention Program: Data Glossary

This is an overview of data presented on this dashboard. The Injury & Violence Prevention Program (IVPP) uses other data sources outlined here: IVPP Data Glossary

Data Description

State Unintentional Drug Overdose Reporting System (SUDORS)

Data come from death certificate information, medical examiner or coroner reports, and forensic toxicology results entered into the State Unintentional Drug Overdose Reporting System (SUDORS). Jurisdictions report occurrent drug overdose deaths (i.e., all overdose deaths that occurred within the jurisdiction regardless of decedent residence).

The number of deaths, and corresponding rates, in SUDORS might not match the number and rate in CDC’s Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) or the death data on this dashboard.

For national SUDORS data, visit the CDC SUDORS Dashboard: Fatal Drug Overdose Data Dashboard.


Emergency Department and Hospital Stays

Health care information on this dashboard is administrative discharge data (emergency department and hospital visits) from the Hospital Association of Oregon (HAO). (link to data source)

Discharge data include hospital and emergency department (ED) visit information. Hospitals and EDs report data to HAO on visits when there is a charge for services. This information includes diagnoses, medical care received, and demographic information of the patient (examples: age, sex, race and ethnicity). Hospital and ED discharge data do not overlap. If a patient goes to an ED first and then is admitted to the hospital, their information will be reported in the hospital discharge data only.

Hospital discharge data include information for hospital visits that were at least 24 hours long. This information does not include outpatient and ED visits. This information has been available since 2000. The diagnosis classifications changed in October 2015, so information after date this cannot be compared directly to earlier information. It takes six months for this data to become available.

Emergency Department discharge data includes information for ED visits. This information has been available since 2018 and takes six months for this data to become available.


Death/Mortality

Death data on this dashboard are available from the Oregon Center for Health Statistics. (CHS) (link to data source)

Death certificates are registered with CHS. Death certificates are completed and signed by a physician, physician’s assistant, nurse practitioner, or medical examiner. The data reported on this dashboard represents drug overdose deaths to Oregon residents who died in Oregon. Oregon began collecting this data in 1903 and is finalized 10 to 11 months after the end of the calendar year.

Definitions


Substance Category Definitions

All Overdose:
Includes any reported drug-related overdose (examples: poisoning by drugs, medications, and biological substances regardless of intention, unintentional, self-harm, harm to others, undetermined, etc.). Note: Categories are not mutually exclusive and therefore the ‘All Overdose’ category will not equal the sum of every category combined.

Any Opioid:
Includes any opioid-related overdose regardless of intention (examples: unintentional, self-harm, harm to others, undetermined, etc.). [ICD-10: T40.1X-T40.4X and T40.6X]

Benzodiazepine:
Includes any benzodiazepine-related overdose, such as alprazolam, chlordiazepoxide, clorazepate, etc., regardless of intention (examples: unintentional, self-harm, harm to others, undetermined, etc.). [ICD-10: T42.4X: Benzodiazepine]

Fentanyl:
Includes any fentanyl related overdose regardless of intention for hospitalization and emergency department only using a new ICD-10 CM code implemented in October 2020 (unintentional, self-harm, harm to others, undetermined, etc.) [ICD-10-CM: T40.41X: Fentanyl]

Heroin:
Includes any heroin-related overdose regardless of intention (examples: unintentional, self-harm, harm to others, undetermined, etc.). [ICD-10: T40.1X: Heroin]

Methadone:
Includes any methadone-related overdose regardless of intention (examples: unintentional, self-harm, harm to others, undetermined, etc.). [ICD-10: T40.3X: Methadone]

Natural & Semi-Synthetic Opioids:
Includes ‘natural’ opioids, non-synthetic opioids, and/or opioids not specified, like codeine. This includes overdoses regardless of intention (examples: unintentional, self-harm, harm to others, undetermined, etc.). [ICD-10: T40.2X: Natural/Semi-Synthetic Opioids]

Stimulant:
Includes any stimulant-related overdose, such as amphetamines, methamphetamines, cocaine, etc., regardless of intention (examples: unintentional, self-harm, harm to others, undetermined, etc.). Note: an ICD-10 CM methamphetamine code for hospitalization and emergency department data was implemented October 2022 and will be reported as it becomes available. [ICD-10: T40.5X: Cocaine & T43.6X: Stimulants]

Synthetic Opioid:
Includes any synthetic-related opioid overdose, such as fentanyl, oxymorphone, oxycodone, regardless of intention (examples: unintentional, self-harm, harm to others, undetermined, etc.). [ICD-10: T40.4X: Synthetic opioids, excluding methadone]

Unintentional and Undetermined Intent:
Includes any unintentional and undetermined intent drug-related overdose (examples: poisoning by drugs, medications, and biological substances).

Unspecified Opioid/Narcotic:
Includes any unspecified opioid and/or narcotic overdose that doesn’t fall into traditional synthetic or ‘natural’ opioids, or those where specific drug information is limited, regardless of intention (examples: unintentional, self-harm, harm to others, undetermined, etc.). [ICD-10: T40.6X: Other and Unspecified Narcotics]

Definition of Injury

Injury is damage or harm to the body that results in an impairment or destruction of health. Injury results from harmful contact with people, objects, substances, or the environment. Examples of injuries include broken bones, cuts, brain and organ damage, poisoning (overdose), and burns. Injuries are identified through a process of surveillance that incorporates multiple data sources, such as death certificates, hospital discharge and emergency department visit data, trauma registries, violent death registries, and prescription drug monitoring data. Injury is described by intent and mechanism and is measured using raw counts as well as statistics including crude rates. Injuries may vary by social factors like age, gender/biological sex, race, ethnicity as well as more specific social determinants of health. Injury is dynamic and varies over time with new and emerging trends.

Technical Notes


Important Data Considerations

Data Sources:

  • Oregon Vital Statistics Mortality Data

  • Oregon Hospital and Emergency Department Discharge Data

  • National Center for Health Statistics (NCHS)

  • State Unintentional Drug Overdose Reporting Program (SUDORS)

  • US Census Bureau

Counts:
Counts are the number of overdoses. See the Data Descriptions and Definitons tab for further information.

Rates:
Rates presented in this dashboard are crude (not age-adjusted) and are per 100,000 persons unless otherwise noted. Death overdose counts and rates are based on residents of Oregon that died in Oregon (example: Oregon residents that died out of state are not included) unless otherwise noted. As a result, rates and counts may differ from other sources, like the CDC. Hospital and emergency department discharge data are based on residents of Oregon that visited an Oregon facility.

Small Numbers:
To protect the privacy of individuals and avoid providing information that could be used to identify individual events, the data are not shown whenever the annual (State-level data) or four-year total counts (County and Demographic-level data) fall below certain thresholds. For death certificate data, when the count is between one and five overdose deaths, neither the count nor rate is shown. For hospital and emergency department discharge data, when the overdose related visit count is between one to nine, neither the count nor rate is shown. When zero overdose deaths or hospital/ED visits were reported, the count and rate are both shown as zero. It is advised that caution is used when interpreting rates presented that are based on fewer than 20 events.

Preliminary Data:
Preliminary data represent information that has not undergone the same quality control measures as the finalized data. This data is shown to provide more recent trends of the overdose crisis in Oregon. Preliminary data may change once finalized and are not available for download.

Demographics:
Because of limitations with the available data with respects to sex and gender, only male and female categories are shown. In death certificates, the decedent’s legal sex is recorded as what was provided on birth certificates and other identity documents; consequently, nonbinary individuals may be undercounted compared to self-reported gender identity. In hospital and emergency department discharge data, the available choices currently include male, female, other, unknown and refuse to answer. This, too, may result in undercounts of nonbinary individuals. In part due to the above deficiencies in data collection, the counts for nonbinary, other, unknown, and refuse to answer do not meet data confidentiality thresholds and have been withheld to protect the privacy of individuals.

Race categories for deaths:
When a person dies in Oregon, more than one race can be reported on their death certificate. This information is not able to be provided by the decedent, so their race and ethnicity information may not accurately reflect how they self-identified. On this dashboard, when more than one race is reported for a person, their least common reported race is used for counts and rates. This is sometimes called rarest race methodology. This approach has its limitations, but it amplifies the representation of Oregon’s smaller communities.

Fentanyl:
ICD-10 codes are used in death certificates for reporting the cause(s) of death. Currently, fentanyl-related deaths are not identifiable by the cause of death ICD-10 codes and must be included in the synthetic opioid death category. For data specific to fentanyl-related deaths, please use the Oregon Medical Examiner and SUDORS-related data from the CDC ; national and state-specific data are available.

Fentanyl coding was implemented for hospitals and emergency departments in October 2020 and should be used with caution. Increasing trends could be influenced by hospital staff gaining familiarity with the new diagnosis code.

Overdose Death Reporting:
The drug overdose deaths included in the dashboard include people with a primary cause or contributing cause of death attributed to a drug overdose. Only Oregon residents who died in Oregon are reported.

Hospital/Emergency Department Overdose Reporting:
Drug overdose hospitalizations and emergency department visits presented in the dashboard include any visit for an Oregon resident who received care in an Oregon facility and had an overdose diagnosis reported in their discharge information.

Caveats and limitations: Each data source used in this dashboard has limitations that warrant caution about interpretation and comparison of data.

Oregon Hospital and Discharge Data: Oregon Hospital and Emergency Department discharge data include all non-federal Oregon acute-care inpatient facilities (that is, all facilities but the Portland Veterans Administration). Hospitalizations include people who had an inpatient or overnight visit, but not visits that result solely in emergency room visits. Emergency department visits include people who were only seen in the emergency department and not admitted into the hospital. Hospitalization data are flagged if any overdose diagnostic codes are reported for the hospitalization, although any person hospitalized may have multiple diagnosis codes reported in their discharge data.

Emergency department data are flagged on any diagnosis or chief complaint codes. Due to Oregon getting emergency department data from 2018 forward, hospitalization and emergency department visits are reported from 2018 forward. Note that case definitions may change over time as ICD-10 diagnosis codes are added or removed.

Hospitalization and emergency department data do not contain personal identifiers that would facilitate identification of multiple admissions, and may include re-admissions, transfers, and visits where the patient died. Counts and rates are based on hospitalizations or emergency department visits and not necessarily unique persons; a person may be counted more than once in hospitalization and/or emergency department estimates if they had multiple visits.

For hospitalization and emergency department data, race is inconsistently reported and a sizable proportion of injury hospitalizations report race as “other” or “unknown”. As a result, the overdose counts and rates for some race categories may not represent the true burden of overdose hospitalization or emergency department visits.




Last Updated: 2025-08-19

This dashboard was made possible by the Centers for Disease Control and Prevention (CDC) under the non-research cooperative agreement CDC-RFA-CE-23-0002: Overdose Data to Action in States (OD2A-S) grant through the National Center for Injury Prevention and Control. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the views of the CDC.